search icon

    Market Snapshot

    • S&P Futures

      3,809.5

    • Dow Futures

      30,868

    • Nasdaq Futures

      11,633.25

    blog search icon

    Atossa Therapeutics, Inc.

    (NASDAQ:ATOS)

    $1.09

    $-0.07

    -6.03%

    Atossa Therapeutics, Inc. Chart

    ATOS Stock Price Today

    Atossa Therapeutics, Inc. (ATOS) stock declined over -6.03% intraday to trade at $1.09 a share on NASDAQ. The stock opened with a loss of -6.03% at $1.13 and touched an intraday high of $1.16, falling -6.03% against the last close of $1.16. The stock went to a low of $1.08 during the session.

    Stock Snapshot

    $1.16

    Prev. Close

    138.02 Million

    Market Cap

    $1.08

    Day Low

    $1.13

    Open

    126.62 Million

    Number of Shares

    $1.16

    Day High

    -

    P/E ratio

    -0.17

    EPS (TTM)

    1.08

    Cash Flow per Share

    12.84

    Free Float in %

    1.11

    Book Value

    1,004,307

    Volume

    Atossa Therapeutics, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-30$1.13$1.16$1.08$1.091,003,325
    2022-06-29$1.16$1.18$1.11$1.16680,500
    2022-06-28$1.22$1.22$1.15$1.15891,800
    2022-06-27$1.23$1.24$1.15$1.211,363,900
    2022-06-24$1.11$1.21$1.11$1.1717,255,100
    2022-06-23$1.09$1.12$1.05$1.121,476,400
    2022-06-22$1.04$1.12$1.03$1.071,227,100
    2022-06-21$1.08$1.08$1.01$1.041,694,700
    2022-06-17$1.01$1.09$1$1.041,715,400
    2022-06-16$1.01$1.03$1$1.011,252,300

    Contact Details

    107 Spring Street
    Seattle, WA 98104
    United States

    Webiste:ATOS

    206 588 0256

    Company Information

    Employees-

    Beta1.8

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

    Frequently Asked Questions

    icon

    What is the current Atossa Therapeutics, Inc. (ATOS) stock price?

    Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock price is $1.09 as of the last check on Thursday, June 30. During the trading session, ATOS stock reached the peak price of $1.16 while $1.08 was the lowest point it dropped to.

    icon

    ATOS's industry and sector of operation?

    The NASDAQ listed ATOS is part of Biotechnology industry that operates in the broader Health Care sector. Atossa Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases.

    icon

    Who are the executives of ATOS?

    Dr. Steven C. Quay FCAP, M.D., Ph.D.
    Chairman, CEO & Pres
    Mr. Kyle Guse CPA, Esq., CPA
    CFO, Gen. Counsel & Sec.
    Ms. Heather Rees
    VP of Fin. & Accounting
    Ms. Delly Behen P.H.R.
    VP of Admin. & HR

    icon

    What is the ATOS stock price today?

    ATOS stock traded closed the last session at $1.09, which is $-0.07 or -6.03% lower than its previous close of $1.16. ATOS's current trading price is 30.52% lower than its 52-week high of $7.15 where as its distance from 52-week low of 0.84% is -84.76%.

    icon

    How many employees does ATOS have?

    Number of ATOS employees currently stands at -. ATOS operates from 107 Spring Street, Seattle, WA 98104, United States.

    icon

    Link for ATOS official website?

    Official Webiste of $ATOS is: https://www.atossatherapeutics.com

    icon

    How do I contact ATOS?

    ATOS could be contacted at ATOS operates from 107 Spring Street, Seattle, WA 98104, United States, or at phone #206 588 0256 and can also be accessed through its website.

    icon

    How many shares of ATOS are traded daily?

    ATOS stock volume for the day was 1,004,307 shares while in the previous session number of ATOS shares traded was 1,003,325 . The average number of ATOS shares traded daily for last 3 months was 1.83 Million.

    icon

    How much did ATOS change today?

    The percentage change in ATOS stock occurred in the recent session was -6.03% while the dollar amount for the price change in ATOS stock was $-0.07.

    icon

    What price range ATOS stock been trading in?

    In the recent session, the day high for ATOS stock was $1.16 while the low for ATOS stock touched on the day was $1.08.

    icon

    What is the market cap of ATOS currently?

    The market value of ATOS currently stands at 138.02 Million with its latest stock price at $1.09 and 126.62 Million of its shares outstanding.